A reconstituted telomerase-immortalized human corneal epithelium in vivo: A pilot study

Current Eye Research

Volumn 36, Issue 8, 2011, Pages 706-712

  Robertson, Danielle M ^a   Kalangara, Jerry P ^a   Baucom, Rebeccah B ^a   Petroll, W Matthew ^a   Cavanagh, H Dwight ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cornea; Differentiation; Epithelium; Limbal niche; Telomerase

Indexed keywords

GANCICLOVIR; MITOMYCIN C; MONOCLONAL ANTIBODY; PHALLOIDIN; RETROVIRUS VECTOR; TELOMERASE; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL DEATH; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CORNEA EPITHELIUM; DEBRIDEMENT; DRUG EFFICACY; EPITHELIUM CELL; EPITHELIZATION; FEMALE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; SUICIDE GENE; TISSUE ENGINEERING;

ANIMALS; CELL ADHESION; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CELLS, CULTURED; CORNEAL DISEASES; DEBRIDEMENT; DISEASE MODELS, ANIMAL; EPITHELIUM, CORNEAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GANCICLOVIR; GENES, TRANSGENIC, SUICIDE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; PILOT PROJECTS; TELOMERASE; THYMIDINE KINASE;

EID: 79960745591     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2011.582662     Document Type: Article

References (32)

1. Cotsarelis G, Cheng SZ, Dong G, Sun TT, Lavker RM. Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: Implications on epithelial stem cells. Cell. 1989;57:201-209 (Pubitemid 19112360)
2. Lavker RM, Tseng SC, Sun TT. Corneal epithelial stem cells at the limbus: Looking at some old problems from a new angle. Exp Eye Res. 2004;78:433-446. (Pubitemid 38183322)
3. Lavker RM, Dong G, Cheng SZ, Kudoh K, Cotsarelis G, Sun TT. Relative proliferative rates of limbal and corneal epithe-lia. Implications of corneal epithelial migration, circadian rhythm, and suprabasally located DNA-synthesizing kera-tinocytes. Invest Ophthalmol Vis Sci. 1991;32:1864-1875.
4. Ladage PM, Yamamoto K, Ren DH, Li L, Jester JV, Petroll WM, Bergmanson JPG, Cavanagh HD. Proliferation rate of rabbit corneal epithelium during overnight rigid contact lens wear. Invest Ophthalmol Vis Sci. 2001;42:2804-2812. (Pubitemid 33035276)
5. Yamamoto K, Ladage PM, Ren DH, Li L, Petroll WM, Jester JV, Cavanagh HD. Bcl-2 expression in the human cornea. Exp Eye Res. 2001;73:247-255. (Pubitemid 32977955)
6. Ren H, Wilson G. Apoptosis in the corneal epithelium. Invest Ophthalmol Vis Sci. 1996;37:1017-1025. (Pubitemid 26164233)
7. Araki-Sasaki K, Ohashi Y, Sasabe T, Hayashi L, Watanabe H, Tano Y, Handa H. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci. 1995;36:614-621.
8. Mohan RR, Possin DE, Mohan RR, Sinha S, Wilson SE: Development of genetically engineered tet HPV 16-E6/E7 transduced human corneal epithelial clones having tight regulation of proliferation and normal differentiation. Exp Eye Res. 2003;77:395-407. (Pubitemid 37040839)
9. Offord EA, Sharif NA, Mace K, Tromvoukis Y, Spillare EA, Avanti O, Howe WE, Pfeifer AMA. Immortalized human corneal epithelial cells for ocular toxicity and infammation studies. Invest Ophthalmol Vis Sci. 1999;40: 1091-1101. (Pubitemid 29211446)
10. Kahn CR, Young E, Lee IH, Rhim JS. Human corneal epithelial primary cultures and cell lines with extended life span: In vitro model for ocular studies. Invest Ophthalmol Vis Sci. 1993;34:3429-3441. (Pubitemid 23346676)
11. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349-352. (Pubitemid 28063364)
12. Robertson DM, Li L, Fisher S, Pearce VP, Shay JW, Wright WE, Cavanagh HD, Jester JV. Characterization of growth and differentiation in a telomerase-immortalized human corneal epithelial cell line. Invest Ophthalmol Vis Sci. 2005;46:470-478. (Pubitemid 40270324)
13. Shay JW, Wright WE. The use of telomerized cells for tissue engineering. Nature Biotech. 2000;18:22-23. (Pubitemid 30041163)
14. Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SIS, Jensen TG, Kassem M. Telomerase expression extends the proliferative life-span and maintains the osteo-genic potential of human bone marrow stromal cells. Nature Biotech. 2002;20:592-596. (Pubitemid 34595153)
15. Jiang X-R, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AG, Wahl GM, Tlsty TD, Chiu C-P. Telomerase expression in human somatic cells does not induce changes associated iwth a transformed phenotype. Nature Genetics. 1999;21:111-114.
16. Mondello C, Chiesa M, Rebuzzini P, Zongaro S, Verri A, Colombo T, Giulotto E, D'Incalci M, Franceschi C, Nuzzo F. Karyotype instability and anchorage-independent growth in telomerase-immortalized fbroblasts from two centenarian individuals. Biochem Biophys Res Commun. 2003; 308(4): 914-921 (Pubitemid 36976546)
17. Dachs GU, Tupper J, Tozer GM. From bench to bedside for gene-directed enzyme prodrug therapy of cancer. Anti-Cancer Drugs. 2005;16:349-359. (Pubitemid 40434601)
18. Knox RJ. Gene-directed enzyme prodrug therapy (GDEPT)- recognizing the present limitations of gene therapy for the treatment of cancer. Curr Opin Invest Drugs. 2001;2:835-838. (Pubitemid 32936679)
19. Greco O, Dachs GU. Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectives. J Cell Physiol. 2001;187:22-36. (Pubitemid 32195242)
20. Denny WA. Prodrugs for gene-directed enzyme-prodrug therapy (suicide gene therapy). J Biomed Biotech. 2003;1:48-70. (Pubitemid 36828274)
21. Rosenberg AS, Mizuochi T, Sharrow SO, Singer A. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. J Exp Med. 1987;165:1296-1315. (Pubitemid 17073529)
22. Doran TI, Vidrich A, Sunk, T-T. Intrinsic and extrinsic regulation of the differentiation of skin, corneal and esophageal epithelial cells. Cell. 1980;22:17-25. (Pubitemid 11226424)
23. Rajan MS, O'Brart DPS, Patmore A, Marshall J. Cellular effects of mitomycin-C on human corneas after photorefrac-tive keratectomy. J Cataract Refract Surg. 2006;32:1741-1747. (Pubitemid 44436844)
24. Sadeghi HM, Seitz B, Hayashi S, La Bree L, McDonnell PJ. In vitro effects of mitomycin-C on human keratocytes. J Refract Surg. 1998;14:534-540. (Pubitemid 28460914)
25. Cintron C, Hassinger L, Kublin CL, Friend J. A simple method for the removal of rabbit corneal epithelium utilizing n-hep-tanol. Ophthalmic Res. 1979;11:90-96. (Pubitemid 10235400)
26. Homma R, Yoshikawa H, Takeno M, Kurokawa MS, Masuda C, Takada E, Tsubota K, Ueno S, Suzuki N. Induction of epithelial progenitors in vitro from mouse embryonic stem cells and application for reconstruction of damaged cornea in mice. Invest Ophthalmol Vis Sci. 2004;45:4320-4326. (Pubitemid 39564656)
27. Wu KY, Hong SJ, Huang HT, Lin CP, Chen CW. Toxic effects of mitomycin-C on cultured corneal keratocytes and endothe-lial cells. J Ocul Pharmacol Ther. 1999;15:401-411.
28. Song J-S, Kim J-H, Yang M, Sul D, Kim H-M. Mitomycin-C concentration in cornea and aqueous humor and apoptosis in the stroma after topical mitomycin-C application. Cornea. 2007;26:461-467. (Pubitemid 46684388)
29. Ahuja D, Saenz-Robles MT, Pipas JM. SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene. 2005;24:7729-7745. (Pubitemid 41670675)
30. Butel JS. Viral carcinogenesis: Revelation of molecular mechanisms and etiology of human disease. Carcinogenesis. 2000;21:405-426. (Pubitemid 30137926)
31. Lo H-W, Day C-P, Hung M-C. Cancer-specific gene therapy. Advan Genetics. 2005;54:235-255.
32. Varley AW, Munford RS. Physiologically responsive gene therapy. Mol Med Today. 1998;4(10):445-451. (Pubitemid 28464833)